ValuEngine Upgrades Medicis Pharmaceutical To ‘5’ Rating
<p>September 30, 2009 (FinancialWire) (Investrend Research Syndicate) — ValuEngine, Inc. has upgraded Medicis Pharmaceutical Corp (NYSE: MRX) to a “5″ rating, the service’s highest.</p> <p>The …